erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the .
over years of research, scientists discovered that cgrp helps transmit pain signals in the brain. .
![facebook](/www.centralmaine.com/wp-content/themes/mainetoday/assets/images/fb-reverse.png)
not coincidentally, maine has a high rate of whooping cough cases � 21.1 per 100,000 people in 2015, compared to 10.3 per 100,000 nationwide. .